贵圈
政府都对党
- 注册
- 2014-10-21
- 消息
- 32,808
- 荣誉分数
- 6,137
- 声望点数
- 373
1. 印度从高峰回落。到今天为止
使用HCQ。AVM。AVM今年大量使用。疫苗注射率10%
看来疫苗只要不能到有效率90%以上，而且持续在90%以上，基本上对控制股价级别的感染曲线，没有意义了。
以色列mRNA能够达到90%的时候，感染控制住了。但是随后，因为Delta和时间关系，降到50%有效率，就控制不住。应验在美国，以色列，将来会在加拿大应验的。印度大概率是因为天然免疫能力，和IVM。
巴西，去年一直就没什么控制，基本上是顺其自然。27.7%注射率，使用HCQ AVM, AVM今年是大量使用！这个国家如果有个人抵抗力，大概率是自然康复后的天然防疫能力，和IVM。和疫苗没啥大关系。
智利，HCQ IVM大国，疫苗疫苗接种率70%，七月份以前，
WRITER: BLOOMBERG NEWS
Researchers found CoronaVac was 66% effective in preventing Covid-19 among fully vaccinated adults, versus 93% for the jab made by Pfizer and its partner BioNTech.
The inactivated inoculation, given to more than 10 million Chileans, was slightly less effective in preventing hospitalisation and deaths than the mRNA vaccine, which was administered to fewer than half a million people, according to the study, published Wednesday in the New England Journal of Medicine.
The research was conducted from February through May, when the alpha and gamma strains of the virus were the variants of concern most frequently detected in Chile. Preliminary data released in April found CoronaVac was 67% effective in preventing symptomatic Covid-19 infections and warded off 80% of fatalities from the disease.
The final results suggest CoronaVac, the mainstay of Chile’s vaccination strategy, provides an effective shield against Covid-19, including severe disease, consistent with the results of mid-stage trials, the authors said.
As of May 10, Chile’s Ministry of Health has administered almost 14 million CoronaVac doses, including enough to fully immunise 6.36 million people. In comparison, 2.4 million doses of the Pfizer-BioNTech vaccine had been administered. Individuals 16 years or older are eligible to be immunised, according to the national vaccination schedule.
The study was funded by Chile’s National Research and Development Agency.
七月份以后，智利的确是在下降，原因有可能与疫苗和AVM和波形有关。智利有个特点，多数人打完第一针，后没有按时打第二针，夏天爆发了，才打第二针，结果可能歪打正着。而且智利流行的好像不是Delta。。。
最后是阿联酋，小国，极富国家，疫苗第三针很积极，早就开打了，而且混合了mRNA，所以其国家曲线没啥意义了。很难推测其曲线变化的真正原因。
世界上，除了以色列，可以作为国家级别的试验场，说明单独因素的作用，（足够人口，足够开放，单一疫苗。。。）其他国家，基本上没有太大意义，新冠就是此起彼伏。但是，基本上，目前看，
凡是曲线在八月份走低的，基本上都不限制使用HCQ IVM，这一点倒是很明确。
国家层面不压制HCQIVM的情况不一定证明这两个药一定神药，但是至少证明这个国家是明智的不受"药厂医学"的控制。
比较国家曲线，意义越来越小了，随着时间推移，后期因素越来越多，分析出逻辑关系的可靠性就越来越弱。进行强关联，需要强力的医学数据，统计数字已经很难帮助分析单一因素了。
希望这篇原创，把那些看国家曲线，想证明单一手段的效用的同学们，可以知道其复杂性。（以色列除外）
使用HCQ。AVM。AVM今年大量使用。疫苗注射率10%
看来疫苗只要不能到有效率90%以上，而且持续在90%以上，基本上对控制股价级别的感染曲线，没有意义了。
以色列mRNA能够达到90%的时候，感染控制住了。但是随后，因为Delta和时间关系，降到50%有效率，就控制不住。应验在美国，以色列，将来会在加拿大应验的。印度大概率是因为天然免疫能力，和IVM。
巴西，去年一直就没什么控制，基本上是顺其自然。27.7%注射率，使用HCQ AVM, AVM今年是大量使用！这个国家如果有个人抵抗力，大概率是自然康复后的天然防疫能力，和IVM。和疫苗没啥大关系。
智利，HCQ IVM大国，疫苗疫苗接种率70%，七月份以前，
Sinovac shot found inferior to Pfizer's in Chile study
PUBLISHED : 8 JUL 2021 AT 15:57WRITER: BLOOMBERG NEWS
- A woman receives a dose of Sinovac's CoronaVac coronavirus disease vaccine at a vaccination centre as the sanitary authority starts a vaccination campaign for under 30-year-old people in Santiago, Chile, on May 25 this year. (Reuters photo)
Researchers found CoronaVac was 66% effective in preventing Covid-19 among fully vaccinated adults, versus 93% for the jab made by Pfizer and its partner BioNTech.
The inactivated inoculation, given to more than 10 million Chileans, was slightly less effective in preventing hospitalisation and deaths than the mRNA vaccine, which was administered to fewer than half a million people, according to the study, published Wednesday in the New England Journal of Medicine.
The research was conducted from February through May, when the alpha and gamma strains of the virus were the variants of concern most frequently detected in Chile. Preliminary data released in April found CoronaVac was 67% effective in preventing symptomatic Covid-19 infections and warded off 80% of fatalities from the disease.
The final results suggest CoronaVac, the mainstay of Chile’s vaccination strategy, provides an effective shield against Covid-19, including severe disease, consistent with the results of mid-stage trials, the authors said.
As of May 10, Chile’s Ministry of Health has administered almost 14 million CoronaVac doses, including enough to fully immunise 6.36 million people. In comparison, 2.4 million doses of the Pfizer-BioNTech vaccine had been administered. Individuals 16 years or older are eligible to be immunised, according to the national vaccination schedule.
The study was funded by Chile’s National Research and Development Agency.
七月份以后，智利的确是在下降，原因有可能与疫苗和AVM和波形有关。智利有个特点，多数人打完第一针，后没有按时打第二针，夏天爆发了，才打第二针，结果可能歪打正着。而且智利流行的好像不是Delta。。。
最后是阿联酋，小国，极富国家，疫苗第三针很积极，早就开打了，而且混合了mRNA，所以其国家曲线没啥意义了。很难推测其曲线变化的真正原因。
世界上，除了以色列，可以作为国家级别的试验场，说明单独因素的作用，（足够人口，足够开放，单一疫苗。。。）其他国家，基本上没有太大意义，新冠就是此起彼伏。但是，基本上，目前看，
凡是曲线在八月份走低的，基本上都不限制使用HCQ IVM，这一点倒是很明确。
国家层面不压制HCQIVM的情况不一定证明这两个药一定神药，但是至少证明这个国家是明智的不受"药厂医学"的控制。
比较国家曲线，意义越来越小了，随着时间推移，后期因素越来越多，分析出逻辑关系的可靠性就越来越弱。进行强关联，需要强力的医学数据，统计数字已经很难帮助分析单一因素了。
希望这篇原创，把那些看国家曲线，想证明单一手段的效用的同学们，可以知道其复杂性。（以色列除外）
最后编辑:
